PRADIP SAHA to Follow-Up Studies
This is a "connection" page, showing publications PRADIP SAHA has written about Follow-Up Studies.
Connection Strength
0.005
-
Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment. Am J Respir Crit Care Med. 2002 Oct 01; 166(7):916-9.
Score: 0.005